Endovenous Laser Therapy Market Size to Exceed USD 828.2 Mn by 2032

The Endovenous Laser Therapy Market, estimated at USD 499.2 Mn in 2025, is expected to exhibit a CAGR of 7.5% and reach USD 828.2 Mn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

Key market players are focused on adopting growth strategies such as acquisition and partnerships, which will drive the Global Endovenous Laser Therapy market. For instance, in September 2025, AngioDynamics is medical technology company, announced Commercial Launch of Auryon Atherectomy System to remove some amount of plaque or other material from an atherosclerotic vessel. Next Generation of Peripheral Atherectomy Technology in laser system in the U.S.

Global Endovenous Laser Therapy  Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a positive impact on the Global Endovenous Laser Therapy  market. For instance, in May 2025, according to article published in BMC Nursing, in February 2025, reported varicose veins are considered one of the most common chronic venous disorders, affecting 20-60% of all adults globally. Varicose veins and its risk factors among nurses at Dhulikhel hospital: a cross sectional study.

Global Endovenous Laser Therapy  Market: Key Developments

Additionally, workshops and seminars related to venous vein across the world to endovenous laser therapy promote are expected to boost market growth during the forecast period.

For instance, in December 2025, Surekha Training Centre is Varicose Veins Clinic in india, organized workshop on Training for General Surgeons in Laser Treatments of Varicose Veins in that the delegate was spend an entire day at the vein clinic observing live procedures, hands on opportunity and interacted with the faculty.

In March 2025, Medtronic plc, a U.S.-based medical device company, launched an Investigation Device Exemption (IDE) study to determine the effectiveness and safety of the Abre venous self-expanding stent system to be used in the treatment of deep venous diseases. Around 200 subjects are likely to be enrolled in this study across 35 locations throughout the U.S. and Europe.

Browse 34 Market Data Tables and 26 Figures spread through 176 Pages and in-depth TOC on “Global Endovenous Laser Therapy Market”- Forecast to 2032, Global Endovenous Laser Therapy  Market, by Product Type (Endovenous Laser Systems (Diode Lasers and Yag Lasers) and  Endovenous Laser (Fibers Bare Tip Laser Fibers, Radial Tip Laser Fiber and Gold tip Laser Fiber)), By End user (Hospitals, Ambulatory Surgical Centers and Specialty Clinics),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below::

https://www.coherentmarketinsights.com/market-insight/endovenous-laser-therapy-market-3377

Key Takeaways of the global endovenous laser therapy market :

• The global endovenous laser therapy market is expected to exhibit a CAGR of 7.5% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global endovenous laser therapy  market. The spread of endovenous laser system technologies has been driven by high public awareness in developed economies such as the U.S. and Europe.
• Among Product Type, the Laser Systems (Diode Lasers and Yag Lasers) segment is expected to hold a dominant position in the global endovenous laser therapy market during the forecast period and this is attributed to the technological advancements in the field of endovenous laser therapy.
• Among region, North America is expected to be the dominant region in the global endovenous laser therapy market, owing to the key players are focusing on inorganic strategies partnership with the companies. For instance, in June 2025, AngioDynamics, Inc., a U.S.-based medical device manufacturer, the U.S. Food and Drug Administration (FDA) accepted its distribution partnership, Medcomp Inc.'s in dialysis access therapy in harleyville, introduced Celerity tip location system is adjunct to aid in positioning Peripherally Inserted Central Catheters.Correspondingly, North America's share in the global market for endovenous laser therapy is also expected to remain dominant through 2032.
• Major players operating in the global endovenous laser therapy market include Syneron Medical Ltd., AngioDynamics, Inc., Candela Corporation, Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, Wontech Co., Ltd., Intros Medical Laser GmbH, biolitec AG, EUFOTON S.R.L , Teleflex Incorporated, Boston Scientific Corporation, Merit Medical Systems, Sciton, Inc. and Energist Ltd.